Palvella reports positive findings on rapamycin for venous malformations
PositiveFinancial Markets

Palvella has announced promising results from its research on rapamycin, a drug that shows potential in treating venous malformations. This is significant as these conditions can lead to serious health issues, and effective treatments are limited. The positive findings could pave the way for new therapies, improving the quality of life for many patients.
— Curated by the World Pulse Now AI Editorial System